SRPT Sarepta Therapeutics, Inc.
Healthcare$16.80-0.94%ClosedMarket Cap: $1.77B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$25.14
Target (Median)
$25.00
Target Range
$14.00 - $35.00
Upside from current price: 49.6%
Rating Distribution
0 Strong Buy8 Buy13 Hold3 Sell2 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-16 | HC Wainwright & Co. | maintain | Sell | Sell |
| 2026-03-26 | Needham | maintain | Underperform | Underperform |
| 2026-03-26 | Citigroup | maintain | Sell | Sell |
| 2026-03-19 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-03-13 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-02 | HC Wainwright & Co. | maintain | Sell | Sell |
| 2026-02-27 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-01-27 | HC Wainwright & Co. | maintain | Sell | Sell |
| 2026-01-23 | Wedbush | maintain | Outperform | Outperform |
| 2025-11-05 | Barclays | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.95 | $1.42B | 12 |
| Sun Dec 31 | $0.80 | $1.40B | 12 |
| Mon Dec 31 | $0.41 | $1.34B | 10 |
| Tue Dec 31 | $0.39 | $1.31B | 5 |